Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.46 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25279034 | 0.81 | CA2 (0.46) | CA2NISCHHTTALDH1A1HPGD | |
| SCHEMBL11412570 | 0.81 | CA2 (0.48) | CA2NISCHHTTALDH1A1SMN1; SMN2 | |
| SCHEMBL30464074 | 0.81 | CA2 (0.46) | CA2NISCHHTTALDH1A1HPGD | |
| SCHEMBL5864109 | 0.81 | CA2 (0.54) | CA2NISCHHTTALDH1A1ALOX5 | |
| SCHEMBL11429642 | 0.77 | CA2 (0.47) | CA2ALDH1A1HPGDSMN1; SMN2MTNR1A | |
| SCHEMBL1479943 | 0.77 | SMN1; SMN2 (0.52) | CA2HTTSMN1; SMN2KMT2A | |
| SCHEMBL9662181 | 0.77 | CA2 (0.47) | CA2NISCHHTTHPGDSMN1; SMN2 | |
| SCHEMBL4901600 | 0.77 | SMN1; SMN2 (0.52) | CA2HTTSMN1; SMN2KMT2A | |
| Sulfuric Acid SCHEMBL29003462 | 0.76 | CA2 (0.45) | CA2NISCHHTTALDH1A1HPGD | |
| SCHEMBL11072331 | 0.74 | HPGD (0.43) | CA2NISCHHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8575392-B2 | Charge-transporting varnish | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-11-05 | — | — | US | claimed |
| EP-2042484-B1 | CHARGE-TRANSPORTING VARNISH | NISSAN CHEMICAL IND LTD (JP) | 2012-09-05 | — | — | EP | claimed |
| EP-1640372-B1 | 1,4-BENZODIOXANE SULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | NISSAN CHEMICAL IND LTD (JP) | 2012-08-01 | — | — | EP | claimed |
| US-7771842-B2 | 1,4-benzodioxane sulfonic acid compound and use thereof as electron-acceptor material | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-10 | — | — | US | claimed |
| US-20090269688-A1 | CHARGE-TRANSPORTING VARNISH | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-10-29 | — | — | US | claimed |
| EP-2042484-A1 | CHARGE-TRANSPORTING VARNISH | Nissan Chemical Industries, Ltd. (JP) | 2009-04-01 | — | — | EP | claimed |
| US-20070105030-A1 | 1, 4-Benzodioxane sulfonic acid compound and use thereof as electron-acceptor material | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-05-10 | — | — | US | claimed |
| EP-1640372-A1 | 1,4-BENZODIOXANE SULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | Nissan Chemical Industries, Ltd. (JP) | 2006-03-29 | — | — | EP | claimed |
| CN-111492497-B | Charge-transporting varnish and charge-transporting film | 日产化学株式会社 | 2023-05-26 | — | — | CN | disclosed |
| US-10847725-B2 | Sulfonic acid ester compound and use therefor | NISSAN CHEMICAL CORPORATION (JP) | 2020-11-24 | — | — | US | disclosed |
| US-20200339825-A1 | CHARGE TRANSPORTING VARNISH AND CHARGE TRANSPORTING THIN FILM | NISSAN CHEMICAL CORPORATION (JP) | 2020-10-29 | — | — | US | disclosed |
| EP-3731291-A1 | CHARGE-TRANSPORTING VARNISH AND CHARGE-TRANSPORTING THIN FILM | Nissan Chemical Corporation (JP) | 2020-10-28 | — | — | EP | disclosed |
| EP-3730477-A1 | SULFONIC ACID ESTER COMPOUND AND USE OF SAME | Nissan Chemical Corporation (JP) | 2020-10-28 | — | — | EP | disclosed |
| US-20200317609-A1 | SULFONIC ACID ESTER COMPOUND AND USE OF SAME | NISSAN CHEMICAL CORPORATION (JP) | 2020-10-08 | — | — | US | disclosed |
| CN-1829706-A | 1, 4-benzodioxan sulfonic acid compound and use thereof as electron acceptor substance | NISSAN CHEMICAL IND LTD (JP) | 2006-09-06 | — | — | CN | disclosed |
| CN-1829706-A | 1, 4-benzodioxan sulfonic acid compound and use thereof as electron acceptor substance | NISSAN CHEMICAL IND LTD (JP) | 2006-09-06 | — | — | CN | disclosed |
| US-20060116512-A1 | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents | GLAXO GROUP LIMITED (GB) | 2006-06-01 | — | — | US | disclosed |
| EP-1640372-A1 | 1,4-BENZODIOXANE SULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | Nissan Chemical Industries, Ltd. (JP) | 2006-03-29 | — | — | EP | disclosed |
| EP-1640372-A1 | 1,4-BENZODIOXANE SULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | Nissan Chemical Industries, Ltd. (JP) | 2006-03-29 | — | — | EP | disclosed |
| WO-2005000832-A1 | 1,4-BENZODIOXANE SULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105030-A1 | 1, 4-Benzodioxane sulfonic acid compound and use thereof as electron-acceptor material | USE1, SLC9A1, ELOVL1 | CA2 1456/4885NISCH 1677/4885HTT 2621/4885 |
| US-10847725-B2 | Sulfonic acid ester compound and use therefor | FFAR4, CYP4F11, SLC46A1 | CA2 2043/4885NISCH 312/4885HTT 2870/4885 |
| US-20200317609-A1 | SULFONIC ACID ESTER COMPOUND AND USE OF SAME | CYP2S1, OR10J3, ACAD11 | CA2 544/4885NISCH 883/4885HTT 2976/4885 |
| US-20090269688-A1 | CHARGE-TRANSPORTING VARNISH | SLCO2A1, SLCO2B1, SLC43A1 | CA2 476/4885NISCH 1645/4885HTT 906/4885 |
| US-20060116512-A1 | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents | NQO2, NQO1, NPM1 | CA2 4465/4885NISCH 23/4885HTT 2401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.